In vitro testing of daptomycin plus rifampin against methicillin-resistant Staphylococcus aureus resistant to rifampin

Saudi Medical Journal

Volumn 29, Issue 12, 2008, Pages 1726-1729

  Khasawneh, Faisal A ^a,b   Ashcraft, Deborah S ^c   Pankey, George A ^c  

^a KING HUSSEIN CANCER CENTER   (Jordan)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; UNITED STATES;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG THERAPY, COMBINATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS;

EID: 60149093249     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Centers of diseases and prevention (CDC). Staphylococcus aureus resistant to vancomycin-United States. Morb Mortal Wkly Rep 2002; 51: 565-567.
2. Centers of diseases and prevention (CDC). Vancomycin-resistant Staphylococcus aureus-New York. Morb Mortal Wkly Rep 2004; 53: 322-323.
3. Centers of diseases and prevention (CDC). Vancomycin-resistant Staphylococcus aureus-Pennsylvania. Morb Mortal Wkly Rep 2002; 51: 902.
4. Pillai SK, Gold HS, Sakoulas C, Wennersten C, Moellering RC Jr, Eliopoulos GM. Daptomycin nonsuceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in mprF. Antimicrob Agents Chemother 2007; 51: 2223-2225.
5. Credito K, Lin G, Appelbaum P. Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus by time kill methodology. Antimicrob Agents Chemother 2007; 51: 1504-1507.
6. Faville RJ Jr, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG. Staphylococcus aureus endocarditis: Combined therapy with vancomycin and rifampin. JAMA 1978; 240: 1963-1965.
7. Pankey GA, Ashcraft DS, Patel N. In vitro synergy of daptomycin plus rifampin against enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob Agents Chemother 2005; 49: 5166-5168.
8. Rand KH, Houck H. Daptomycin synergy with rifampin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother 2004; 53: 530-532.
9. Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 1714-1718.
10. Simmons NA. Synergy and rifampicin. J Antimicrob Chemother 1977; 3: 109-111.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI documents M100-S17. Clinical and Laboratory Standards Institute; Wayne (PA): 2007.
12. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard-Seventh Edition. CLSI document M7-A7. Clinical and Laboratory Standards Institute: Wayne (PA); 2006.
13. Clinical and Laboratory Standards Institute/NCCLS. Methods for determining bactericidal activity of antimicrobial agents. Approved standard, M26-A. Clinicl and Laboratory Standards Institute: Wayne(PA); 1999.
14. Pankey GA, Ashcraft DS. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2005; 49: 2959-2964.
15. Farr B, Mandell GL. Rifampin. Med Clin North Am 1982; 66: 157-168.
16. Pillai SK, Moellering RC Jr, Eliopoulos GM. In: Antibiotics in Laboratory Medicine. Lorian V, editor. 5th edition. Lippincott-Williams and Wilkins: Philadelphia, (PA): 2005.
17. Jones WF Jr, Finland M. Antibiotic combinations: Antibacterial action of plasma of normal subjects after oral doses of penicillin V, tetracycline hydrochloride and a combination of both. N England J Med 1957; 256: 869-874.
18. Mwangi MM, Wu SW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci USA 2007; 104: 9451-9456.